Asosiy kontentga oʻtish
AkademScholar
Muassasalar

Pancreas Centre (Canada)

Davlat:
CA
ROR:
https://ror.org/04s8hyg48
2
h-indeks
4
Iqtiboslar
12
Asarlar
6
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
03581001220102023202520262010: Nashrlar 1, Iqtiboslar 02023: Nashrlar 0, Iqtiboslar 12025: Nashrlar 8, Iqtiboslar 12026: Nashrlar 3, Iqtiboslar 2

Iqtibos tarixi

01220102023202520262010: Iqtiboslar 02023: Iqtiboslar 12025: Iqtiboslar 12026: Iqtiboslar 2

Nashr tarixi

03581020102023202520262010: Nashrlar 12023: Nashrlar 02025: Nashrlar 82026: Nashrlar 3

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

01220102023202520262010: h-indeks 02023: h-indeks 12025: h-indeks 12026: h-indeks 2

Eng koʻp iqtibos qilingan asarlar

  1. D4.1 Initial Description of Vertical UCs and Requirements20250 iqtibos
  2. D4.1 Initial Description of Vertical UCs and Requirements20250 iqtibos
  3. D5.1 Sustainable platform and validation requirements definition20250 iqtibos
  4. D5.1 Sustainable platform and validation requirements definition20250 iqtibos
  5. D4.1 Initial Description of Vertical UCs and Requirements20250 iqtibos
  6. D2.1 Sustainability baseline, Use Cases, and Baseline Requirements20250 iqtibos
  7. D5.1 Sustainable platform and validation requirements definition20250 iqtibos
  8. D4.2 Vertical ecosystem E2E integration – concept and approaches20260 iqtibos
  9. D4.2 Vertical ecosystem E2E integration – concept and approaches20260 iqtibos
  10. Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis20260 iqtibos